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Purpose: To explore the decision-making of general practitioners (GPs) concerning treat-
ment with antibiotics and/or oral corticosteroids and hospitalization for COPD patients with 
exacerbations.
Methods: Thematic analysis of seven focus groups with 53 GPs from urban and rural areas in 
Norway, Germany, Wales, Poland, Russia, the Netherlands, and Hong Kong.
Results: Four main themes were identified. 1) Dealing with medical uncertainty: the GPs aimed 
to make clear medical decisions and avoid unnecessary prescriptions and hospitalizations, yet 
this was challenged by uncertainty regarding the severity of the exacerbations and concerns 
about overlooking comorbidities. 2) Knowing the patient: contextual knowledge about the 
individual patient provided a supplementary framework to biomedical knowledge, allowing for 
more differentiated decision-making. 3) Balancing the patients’ perspective: the GPs considered 
patients’ experiential knowledge about their own body and illness as valuable in assisting their 
decision-making, yet felt that dealing with disagreements between their own and their patients’ 
perceptions concerning the need for treatment or hospitalization could be difficult. 4) Outpatient 
support and collaboration: both formal and informal caregivers and organizational aspects of the 
health systems influenced the decision-making, particularly in terms of mitigating potentially 
severe consequences of “wrong decisions” and concerning the negotiation of responsibilities.
Conclusion: Fear of overlooking severe comorbidity and of further deteriorating symptoms 
emerged as a main driver of GPs’ management decisions. GPs consider a holistic understanding 
of illness and the patients’ own judgment crucial to making reasonable decisions under medical 
uncertainty. Moreover, GPs’ decisions depend on the availability and reliability of other formal 
and informal carers, and the health care systems’ organizational and cultural code of conduct. 
Strengthening the collaboration between GPs, other outpatient care facilities and the patients’ 
social network can ensure ongoing monitoring and prompt intervention if necessary and may 
help to improve primary care for COPD patients with exacerbations.
Keywords: COPD exacerbation, antibiotics, oral corticosteroids, hospitalization, primary care, 
decision-making
Introduction
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) account 
for the accelerated decline of lung function, loss of health-related quality of life, high 
morbidity, mortality, and health costs.1 It is estimated that hospitalizations due to COPD 
exacerbations account for 50%–75% of total health costs in the US and Europe.2 A key 
policy objective in many countries is to reduce costly hospitalizations, which can be 
achieved by prevention of exacerbations and early and optimal therapy in primary 
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care.3 Due to their role as gatekeepers to secondary care in 
many countries, general practitioner (GP)s’ initial assessment 
and decision-making are key to determine the most appropri-
ate treatment and in terms of treatment setting (primary or 
secondary care).4 Even though .80% of AECOPD can be 
managed in an outpatient setting, high hospitalization rates 
compose a major concern in COPD care.5 Current outpatient 
treatments are typically short courses of antibiotics and/or 
oral corticosteroids.5 There are great variations in prescrib-
ing, with antibiotics being usually prescribed more often 
than oral corticosteroids. Clinical findings, such as purulent 
sputum, chest findings, high C-reactive protein (CRP) and 
lung function impairment, as well as the exacerbation’s 
severity and number of previous exacerbations have been 
found to be predictors of treatment with antibiotics and 
oral corticosteroids.6–12 However, the therapeutic benefit 
from antibiotics and oral corticosteroids for outpatients is 
inconclusive13,14 and the symptom-based treatment criteria 
in COPD guidelines might be little helpful for GPs to base 
their treatment decisions on.15 Indeed, GPs can find the 
management of patients with AECOPD challenging, mostly 
due to the clinical complexity of multiple comorbidities and 
the patients’ social context.16 Moreover, as in other illness 
contexts, their prescribing and hospitalization decisions may 
be complicated or influenced by time constraints, aspects of 
the patient–physician relationship, availability of resources, 
and organization of health care systems.17–19 However, there 
is a lack of more specific insights into the GPs’ perspective 
on decision-making regarding COPD patients with exacerba-
tions. Therefore, this study aimed to explore GPs’ accounts 
for their decision-making about treatment with antibiotics 
and/or oral corticosteroids and hospitalization for COPD 
patients with exacerbations.
Methods
Design and methodological considerations
This study is inspired by a naturalistic approach to decision-
making, according to which decision-making under “every-
day life” conditions – that are situated in a particular context 
and are often affected by contingencies – cannot be predicted 
or improved by formal models and normative rules.20,21 It 
addresses the disparity between idealized standards of care 
and variations in care that are not always meeting these 
standards,22 and draws on the understanding that GPs’ 
management decisions – even though sometimes appearing 
“irrational” or “inappropriate” from a biomedical, economi-
cal, or public health perspective – are rational in the process 
of caring for a particular patient in a particular situation.23
The study forms part of a cross-national grounded theory 
study using focus group discussions (FGDs).16 FGD can be 
particularly useful in exploring “what people think, how 
they think, and why they think that way”,24 which is why 
this method should be suitable for identifying reasoning 
patterns that shape GPs’ decision-making. The group interac-
tion characteristic of this interview form can stimulate and 
unravel opinions, which are less accessible in individual 
interviews, and gives the participants the opportunity to 
define themselves related to what is relevant or important 
within the topic of interest.24 Contrary to the study of Risør 
et al,16 we based our study on the FGDs with GPs only. The 
results of this study indicate that there are differences in how 
GPs and pulmonary physicians approach decision-making. 
Overall, GPs typically deal with less severely ill patients 
than pulmonary specialists, and treatment with antibiotics 
and/or oral corticosteroids may often be less necessary for 
COPD patients in primary care.13,14 Therefore, we considered 
it important to explore the GPs’ perspective in particular.
sampling and material
The overall study design and data collection is described 
comprehensively in a previously published paper.16 Briefly, 
this study is based on seven FGDs with a total of 53 GPs in 
six European countries (the Netherlands, Russia, Norway, 
Germany, Poland, and Wales) and China (Hong Kong), 
which were sampled purposefully through personal con-
tacts of the researchers and professional networks in each 
country. The sample aimed for and covered urban and rural 
practices (Table 1). The FGDs were conducted in native 
language in March 2011. Moderators were head researchers 
from each country’s network (a professor or doctor in family 
medicine), except for one case that was moderated by a PhD 
student and an epidemiologist. All moderators underwent 
training in the FGD method. The same interview guide, 
collaboratively developed by the initiators of the overall 
research project PEXACO,16 was used in all FGDs. Topics 
comprised assessment and medication, hospitalization, use of 
guidelines, challenging or difficult situations, most important 
problem, self-treatment, smoking cessation, and improve-
ment of clinical practice (some topics served as data for other 
studies).16,25 The interview guide included two patient cases 
to prompt discussions on the first two topics (Supplementary 
material). The FGDs were transcribed verbatim from audio 
recordings by local researchers and translated into English. 
The research team maintained communication throughout the 
whole research process to resolve any issues concerning the 
interpretation of country-specific content in the FGDs.
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Ethical approval was obtained from the appropriate 
bodies in the participating countries (Norway: Regional 
Ethical Committee, Norwegian Social Science Data Services; 
Germany: Ethical guidelines of the University of Rostock, 
according to these guidelines ethical approval is not needed 
for interviews with professionals; the Netherlands: Ethical 
review board of Maastricht University Hospital/Maastricht 
University; Wales: South East Wales Research Ethics 
Committee Panel C; Poland: Bioethical Commission of 
Medical University of Lodz; Russia: Ethics review board of 
the Northern State Medical University, Arkhangelsk; Hong 
Kong: Chinese University of Hong Kong). The participants 
gave written informed consent and received a financial reim-
bursement (funded by the PEXACO project) for participation. 
Before the transcriptions were distributed in the research 
group, identifiers were removed.
analysis
We employed thematic analysis as described by Braun and 
Clarke,26 which offers a stepwise method for analyzing quali-
tative data. Thematic analysis in this version is independent 
of specific theoretical frameworks and may be used flex-
ibly and actively addressing the chosen design of a project, 
while still providing a sound methodological and theoretical 
approach. Apart from our overall interpretive framework and 
assumption that data is situated and relational, we depart 
from a data-driven, inductive, and semantic approach to the 
analysis without applying specific theories but still interpret-
ing patterns and their broader meanings in relation to theory 
or relevant literature.26 NVivo 10 data analysis software27 and 
Mindjet MindManager Professional28 were used as tools to 
organize the transcripts, codes, memos, and relationships 
between them, and to visualize our findings. First, all tran-
scripts were read by JL and MBR, and then initially coded 
by JL. Subsequently, codes were organized and developed 
to preliminary themes and subthemes, comprising the role of 
clinical findings and their interpretation, medical uncertainty, 
and decision-making as a collaborative process. Their further 
development into final themes was based on literature read-
ing, ongoing reflections, and discussions between JL, MBR, 
and HM. During the whole data analysis, codes and themes 
were constantly tested by moving between the data, codes, 
and visual theme maps to ensure that they represented the 
meanings found in the data. Any disagreements were resolved 
through discussions between the authors.
Results
We identified four main themes in the GPs’ accounts for their 
decision-making: dealing with medical uncertainty, knowing 
the patient, balancing the patients’ perspective, and outpatient 
support and collaboration.
Dealing with medical uncertainty
The GPs emphasized that, in order to make a medically 
accountable decision, sufficient clinical information, for 
example, medical history and clinical investigation was 
necessary.
History is important, obviously, if you have got increased 
breathlessness, increased sputum production, particularly, 
if its mucopurulent, if they are feeling unwell, and then you 
Table 1 Overview over recruitment process and over participating general practitioners
Country Methods of recruitment Number 
invited
Number 
responded
Number of 
participants 
Years in general 
practice
Organization 
of participant 
practices
Setting of 
participants 
practices
norway announcement at a meeting 12 7 7 2 months–20 years group practices 
only
rural
germany Written invitation 29 8 8 1,5–20 Both single and 
group practices
Both urban 
and rural 
The netherlands announcement at a meeting 
and personal contacts
59 27 6 3–30 group practices 
only
Both urban 
and rural 
Wales Postal invitation letters send 
in two rounds and followed 
up with telephone calls
136 18 10 4–28 group practices 
only
Both urban 
and rural 
Poland Individual invitations 8 8 8 15–31 Both single and 
group practices
Both urban 
and rural
russia announcement at meetings, 
telephone invitations, personal 
contact, and email invitation
9 8 8 3 months–13 years Both single and 
group practices
Both urban 
and rural
hong Kong email invitations and 
announcement at meetings
12 6 6 6–12 group practices 
only
Urban
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would want to do an examination and then you can see if 
they have got any signs of respiratory distress above what 
they normally have and if there are any signs of pneumonia, 
any signs of infection, and then treat appropriately. That’s 
the sort of way I would manage it. [GP, Wales]
In terms of antibiotics, colored sputum, fever, and high 
CRP levels appeared particularly relevant. For oral corticos-
teroids, the GPs emphasized (severe) dyspnea and certain 
lungs sounds (“wheezing,” “whirring,” or “whimpering”). 
Particularly important regarding hospitalization were clinical 
findings such as cyanosis, edema, or low oxygen saturation, 
but also the impression that a patient was seriously ill. 
But we can look at it in 2–3 days. If he will be evidently 
short of breath, with cyanosis, with symptoms of such a 
serious exacerbation, then there is no joking, he will go to 
the hospital. [GP, Poland]
Yet, even though decision-making seemed straightfor-
ward in the presence of certain symptoms and clinical find-
ings, the discussions revealed that these theoretically decisive 
signs could lose their diagnostic relevance in the context of 
chronic and comorbid illness.
I think it’s difficult because a lot of these patients do have 
chronic [illness], their sputum is chronically um – there is all 
sorts of bacteria – it is difficult to be guided by things such 
as sputum culture because it’s often going to come back as 
positive whether or not it’s acute […]. [GP, Wales]
Indeed, GPs seemed considerably concerned that symp-
toms and clinical signs were often diffuse, and some GPs’ 
mentioned that limited access to diagnostic tests such as 
blood gas analysis, CRP, or pulse oximetry also reduced the 
possibility of making a certain diagnosis.
Overall, making medically “correct” decisions was chal-
lenging when those in need of antibiotics, oral corticosteroids, 
or hospitalizations could not be identified with certainty 
based on symptoms, clinical findings, or diagnostic tests. 
This could make it difficult to balance the benefits and harms 
of a management option.
See if we knew if it was bacterial or you knew that it wasn’t 
bacterial then you wouldn’t have to start the antibiotics and 
start worrying about the warfarin and that it is going to mess 
up the diabetes and all the rest of it. So, if you did have some 
diagnostic certainty it would not create all these other prob-
lems and exacerbate their other conditions. [GP, Wales]
Even though there were some concerns related to unnec-
essary prescribing, such as pharmacological interactions and 
eventually an increased workload, the GPs’ overall attitude to 
treatment was rather precautionary. Such a “better safe than 
sorry” approach seemed associated with their understanding 
that COPD patients tend to be vulnerable due to advanced 
age and comorbidities, and, consequently, at high risk for 
infections and further deterioration. This added a certain 
sense of urgency to the decision-making.
Usually, we should be concerned whether there is an infec-
tive component when we prescribe steroids. Usually, chronic 
COPD patients are weak and if we prescribe steroids for 
them, will it be easy for them to get infections and often I will 
prescribe antibiotics as daily practice. [GP, Hong Kong]
In addition to such rather rational risk assessment, there 
was a clear emotional component in the GPs’ narrations. Par-
ticularly, worries about having overlooked a severe illness, 
mostly heart diseases, could be worrisome and were associ-
ated with unpleasant feelings of regret subsequent to having 
been too restrictive with treatment or hospitalization.
I would say that, well, the worst cases I remember are the 
ones when I didn’t send the people to the hospital – when 
I couldn’t stop thinking about these patients and was 
like “Oooh, how is it going with them?”, I experienced 
sometimes that I had too high a threshold for hospitalizing 
people, […]. [GP, Norway]
Both such memories from individual cases and the rather 
analytical, epidemiological contemplation of risk factors 
associated with COPD seemed to contribute to an understand-
ing of COPD patients as vulnerable patients. In the light of 
diagnostic and prognostic uncertainty, the GPs’ decision-
making for a patient belonging to this patient group seemed 
characterized by an overall sense of alertness and precaution 
to take any risks regarding treatment and hospitalization.
Knowing the patient
Since deciphering the biomedical meaning of symptoms 
and clinical findings could be difficult, the GPs emphasized 
that knowing their patients was essential for reasonable 
decisions.
I just wanted to say. Now we talk a lot, but if you know him, 
then you know whether he already had something like this 
in the past? Do you have the case history, is he compliant? 
Does he take his medication? Or not? [GP, Germany]
Such knowledge acquired through their role as family 
doctors, comprised both clinical and more personal aspects. 
In terms of clinical knowledge, familiarity with a patient’s 
appearance during a stable state and previous exacerba-
tions helped the GPs for instance to make initial, intuitive 
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judgments regarding their patients’ overall condition, and to 
determine the direction of the further assessment. 
It’s easier in a face to face consultation, you can judge it 
much better. Especially when you know them and if they 
walk the corridor to your room you can tell how good or 
bad they are. [GP, Wales]
Such initial judgments were particularly relevant regard-
ing hospitalizations, as they could either increase or decrease 
the perceived risk of further deterioration, eventually trig-
gering immediate hospitalization. It could also create a sense 
of comfort that they were able to manage the patient in an 
outpatient setting. Moreover, knowing the patient’s medical 
history, comorbidities, and maintenance treatment, as well 
as the outcome of previous treatment for a similar condition, 
and how effectively, could reduce uncertainty and enable 
straightforward decision-making. 
Previous history, that is, the last exacerbation was very 
severe and required hospitalization. […] These patients – we 
know them and, naturally, refer to hospital. [GP, Russia]
In terms of personal knowledge, the GPs emphasized 
that knowledge about their patients’ help-seeking behavior, 
their ways to present symptoms, and whether a patient was 
predisposed to anxiety was helpful to judge the “real” severity 
of symptoms and necessity for treatment. 
The first thing is whether the patient is known to me, […]. 
How often has he been in the practice and does he tend to 
be a hypochondriac? [GP, Germany]
Overall, we found that the GPs’ knowledge about a par-
ticular patient could serve as a frame of reference, adding a 
certain sense of security and confidence to the GPs’ assess-
ment and decisions.
Balancing the patients’ perspective
The GPs’ knowledge about their patients also seemed 
important in assessing whether they could rely on the 
patients’ own judgment about the necessity for treatment 
and hospitalization. 
I believe that patients are rather good at assessing that 
themselves. Not all of them of course, but severe and long-
term COPD patients know when something is really wrong. 
[GP, the Netherlands]
Many of the GPs’ stories indicated that they favored 
active involvement of patients in the decision-making, 
being aware of the patients’ experiential knowledge from 
having lived with COPD. Knowledge about the previous 
effectiveness of treatments and hospitalizations were seen as 
particularly valuable. Similarly, the GPs knew that patients’ 
opinions did not necessarily reflect a biomedical need, but 
also the need for relieving anxiety and meeting challenges 
in the patients’ social life.
I think the other thing is why the patient wants antibiotics 
this time, he may have had other exacerbations through the 
year and managed them himself, maybe this time he wants 
to be treated as he’s going on holidays next week or he’s 
been keeping his wife awake and she’s fed up of his coughs, 
maybe find out why this time he feels he’s bad enough to 
want antibiotics. [GP, Wales]
Consequently, there could be discrepancies between the 
GPs’ and patients’ judgments, which the GPs had to bal-
ance. When the GPs considered treatment or hospitalization 
unnecessary but the patient insisted, the GPs had to decide 
whether to make efforts to convince the patients about their 
position or to give into the patients’ requests. While the GPs 
seemed most critical regarding the patients’ opinion about 
antibiotic treatment, they seemed to largely acknowledge 
the patients’ preferences regarding the safe surroundings 
of a hospital. 
If she is a worried lady and self-wants to be in a hospital I 
would set the threshold even lower I suppose. [GP, Norway]
However, more challenging for the GPs were contrary 
situations, in which the GP would prefer medical treatment 
or hospitalization, but the patients refused. 
And it all comes down to the patient’s consent, when he 
says: you won’t get me into a hospital, I can’t do anything. 
[GP, Germany]
According to the GPs, patients might be afraid to take 
oral corticosteroids or did not want to be treated in hospital. 
Lack of patients’ consent to treatment or referral to the hos-
pital seemed particularly challenging for the GPs, as it could 
increase their worries. In such situations, but also, in general, 
possibilities to sharing responsibility emerged as important 
aspects of the GPs decision-making.
Outpatient support and collaboration
The GPs’ emphasized repeatedly that the patients’ social 
context, as well as infrastructural and organizational aspects, 
were highly relevant to their management decisions. Con-
sidering that the GPs often wished to manage patients in an 
outpatient setting but could be worried about further dete-
riorations, reliable outpatient support emerged as one of the 
most important aspects in this regard.
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Sometimes, indeed, the hospitalization is not connected with 
the condition of the patient, not for purely medical reasons, 
but really for social factors. Could the patient reach the day 
care hospital, whether it is possible to organize at home and 
if the doctor and nurse are busy […] Many factors affect 
hospitalization. [GP, Russia]
“Social factors”, as this GP described them, could be 
home support by family members, specialized nurse teams, 
or day care institutions, which could ensure that patients took 
their medications correctly and were monitored by family 
members or health care professionals. In addition to reliable 
home support, social and infrastructural circumstances suffi-
cient to ensure that patients could reach any sort of emergency 
care institution, if needed, seemed crucial to whether the GPs 
considered hospitalization as necessary or not.
Moderator: Ok, then if a patient is at risk when treated at 
home, is there any options in your management other than 
hospitalization?
GP1: In Hong Kong? […]. If the case is so risky, […] 
I cannot think of any [other option].
GP2: In Hong Kong, there is no community nurse 
support.
GP4: It seems that CNS [Community Nursing Service] 
does not cover COPD cases unless they have poor drug 
compliance.
Moderator: Then, all of you can only think of 
hospitalization?
GP3: Actually, we can see whether NGOs [non-
governmental organizations] could help, but if the patients 
are not members of these NGOs, there will not be services 
available for them. [Hong Kong]
Overall, having such “insurances” to reduce the risk 
of severe outcomes seemed to raise the GPs’ readiness to 
assume the risk and try outpatient management in the first 
place, which could be particularly important when dealing 
with patients whose care belonged somewhere between their 
own and the hospitals’ responsibility. Depending on the 
health care systems’ organization, GPs could even create their 
own “insurances,” such as giving patients a “standby” referral 
they could redeem when their condition worsened.
However, a reliable outpatient network could not always 
make for up the GPs’ worries caused by uncertainty regarding 
the underlying cause of symptoms and appropriate treatment. 
In this regard, referring to hospitalizations could not always 
serve pure therapeutic, but also diagnostic purposes.
I think from that worry, from that worry I think if they have 
a co-existing infection possibly maybe pneumonia, I’d be 
admitting them. I think if they need a chest X-ray they need it 
then, as opposed to going next Monday, […]. [GP, Wales]
Referring to diagnostics, however, could also serve the 
purpose of transferring responsibility to secondary care, 
when feeling that a patient’s condition was too severe to 
keep responsibility but lacking a “good” biomedical reason 
to justify hospitalization.
[…], […] sometimes we try […] we don’t write: ‘for 
hospitalization’, but only ‘for diagnostic evaluation in the 
Admission Room’. Sometimes, they ‘buy’ such things […] 
[GP, Russia]
This citation indicates that implementing a certain 
decision that involved other actors within the health care 
system, depends, at least partly, on these actors’ acceptance. 
In fact, some GPs shared their experiences with not finding 
acceptance for their referrals, which forced them to remain 
responsible for patients even though this could be outside 
their own comfort zone.
Discussion
Main findings
The GPs aimed to make accurate medical decisions and 
avoid unnecessary prescriptions/hospitalizations, yet worries 
about having overlooked a severe underlying illness seem 
to fuel “better safe than sorry” decisions. Under medical 
uncertainty, “knowing the patient” provided a supplemen-
tary framework to make sense of the clinical picture and to 
make more differentiated judgments. The GPs considered 
patients’ experiential knowledge about their own body and 
illness as valuable, yet disagreements between their own and 
the patients’ perceptions could be difficult to deal with. Both 
formal and informal caregivers, as well as organizational 
and infrastructural aspects of the health systems, influenced 
the decision-making, particularly in terms of providing 
an “insurance” to reduce the risk of severe consequences 
of “wrong decisions” and concerning the negotiation of 
responsibilities.
Discussion of main findings
role of symptoms and signs
Quantitative investigations on GPs’ prescribing behavior 
for AECOPD (and other respiratory diseases) have shown 
that symptoms and signs such as colored sputum, severe 
dyspnea, and CRP testing are associated with treatment 
decisions for antibiotics and/or oral corticosteroids.29–32 
Our findings confirm that GPs consider these clinical cues 
relevant to their decision-making, yet also show that GPs 
cannot always rely on their presence and significance. 
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Indeed, as Mueller and Tamm stated, “observational studies 
might overestimate the diagnostic value of a marker.”33 In 
the context of chronic illness and comorbidity, differentiat-
ing a “pure” AECOPD from other somatic diseases such as 
pneumonia or heart disease34 and from anxiety35 is probably 
particularly challenging in a primary care setting.
responses to medical uncertainty
Uncertainty due to inconclusive clinical findings refers not 
only to a lack of information but also to emotional responses, 
which may be highly influential in decision-making.36,37 
We found that worries/fear about overlooking a severe ill-
ness were quite dominant emotions in the GPs’ narrations, 
which related to rather categorical precautionary prescrib-
ing and hospitalization. From a psychological perspective, 
such “action rather than inaction”38 may compose a strategy 
to deal with uncertainty through avoiding unpleasant feel-
ings and pondering after the decision is made.39,40 GPs may 
also experience “prescribing against the evidence,” such as 
prescribing antibiotics without proof of bacterial infection, 
as uncomfortable. Yet such rather abstract risks seemed less 
relevant to the GPs’ decision-making18 than more concrete 
risks, whose consequences may not only affect the patient but 
also the GPs themselves.41 Therefore, it may not surprise that 
having an “insurance” seemed related to more risk tolerance 
and motivation to remain responsible for a patient.
holistic understanding of illness
Precautionary decision-making may be regarded as a stress 
response to uncertainty.42,43 Drawing on this concept, Evans 
and Trotter suggested that clinicians with a holistic, biopsy-
chosocial understanding of illness had fewer stress reactions 
to uncertainty than those with the biomedical understanding 
that symptoms always have a detectable biomedical cause.44 
Also, Fairhurst and May suggested that clinician’s knowledge 
about their patients’ “behavior and cognition” is related to 
patient-centered consultation styles and positive consulta-
tion experiences.45 Comparably, our results indicate that a 
holistic interpretative framework based on “knowing the 
patient” is helpful for GPs to make more differentiated and 
confident treatment decisions. Yet, GPs may not always have 
this specific knowledge about their patients.46 Recognizing 
“contextual red flags,” which may address relevant contextual 
issues, under the consultation has been suggested important 
to achieve health benefits for patients.47,48
Involving patients
Adapting care plans to the individual’s contextual circum-
stances would include acknowledging patients’ own opinions 
about symptoms and the most appropriate treatment options. 
Involving patients in treatment decisions is a key concept 
of the shared decision-making model, which is frequently 
promoted in chronic care policies.49,50 This may, however, 
primarily relate to chronic care situations and not so much to 
acute medical situations, which COPD exacerbations after all 
are.51 Moreover, our findings suggest that the patients’ expertise 
seemed most valuable to GPs when feeling unsure themselves. 
Otherwise, patients’ opinions could be “downgraded” to 
“preferences”, sometimes difficult to deal with. Therefore, 
GPs’ motivations to involve patients in the decision-making 
may, at least partly, be a strategy to deal with uncertainty 
rather than reflect implementation of a care concept.52 This 
may be important to consider for the implementation of 
care strategies and policies. A variety of factors influence 
patient involvement in decision-making, including the 
patients’ motivation to be involved and their expectations 
of the consultation.53–56 Importantly, in terms of prescribing 
antibiotics, the clinicians’ perception of the patients’ expec-
tations seems to strongly predict prescribing.57–60 Addressing 
patients’ expectations – rather than teaching them about the 
uselessness of antibiotics on viruses – seem critical in reducing 
unnecessary use of antibiotics.61–63
support from other caregivers and collaboration
According to our findings, not only GPs and patients but also 
patients’ family members, other health care professionals as 
well as organizational and infrastructural factors play a part in 
shaping decisions. The influence of social, health care systems, 
and infrastructural factors on clinical decision-making has 
been described previously, and depending on national and 
local circumstances, such factors may be limiting or enabling 
to GPs’ practice.64,65 Yet, explanations for these statistical rela-
tionships are rare. Our findings suggest that such contextual 
factors’ can affect GPs’ overall risk assessment, for example, 
in providing what we called “security network” or “insurance.” 
Both professional outpatient care services, such as specialist 
nurses providing home visits, and family members could 
embody such an “insurance.” Thus, more important than the 
type of service or the “title” of actors seems their function to 
bear some of the responsibility and to attenuate consequences 
of “wrong” decision. This finding strengthens the importance 
of community-based care services, such as ambulant nursing 
services in COPD care,66 but also of informal caregivers. 
Cooperation between informal caregivers and health care 
professionals can be challenged by different perspectives on 
a conditions’ severity and unclear areas of responsibility.67,68 
Our findings indicate that GPs can face similar challenges in 
cooperation with other health care professionals. For instance, 
when hospital doctors base their judgments on stricter 
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biomedical criteria than GPs.69 Due to not speaking “the same 
language,”69 referral decisions based on a holistic evaluation 
might not match with criteria from more biomedical oriented 
guidelines applied in specialist care.
Strengths and limitations
The study’s cross-cultural design allowed us to look at 
common issues despite different health care systems and 
cultural contexts, and we argue that our findings have uncov-
ered overall aspects relevant to more than just one particular 
setting. Yet, we acknowledge that our focus on common views 
produced in a focus group setting does not allow for specifying 
differences between countries and the role of particular health 
systems and cultural aspects, so the direct applicability of 
our findings in specific settings may be limited. Moreover, 
the GPs in our sample had different backgrounds in terms 
of clinical experience, gender, and workplace, all of which 
may have affected the results. More experienced GPs may for 
instance tolerate more uncertainty,70,71 may therefore be less 
worried than inexperienced GPs, and might therefore refrain 
to a larger extent from precautionary decisions. Female 
GPs may tolerate less uncertainty than male GPs,71 but may 
practice being more patient-centered and spend more time on 
patients,72 perhaps enabling female GPs to better deal with 
uncertainty. GPs in high-frequented practices may be more 
likely to prescribe antibiotics as this is least time consuming73 
and GPs who practice in urban areas with better access to 
specialists may refer more patients than those in rural areas. 
However, this may reflect other differences between urban 
and rural practices.74 Knowing this, we still maintained a 
focus on common views and themes cutting across the sample 
as is often done in FGD analyses, and while no immediate 
implications emerged, we did not explore specifically for 
variations linked to the sample and we may have missed, 
eg, the influence of experiences on practice routines. This 
could be interesting to elaborate in further studies. In terms 
of recruitment, the fact that some participants knew each 
other might have created a safe setting for in-depth discus-
sions, but may also have composed a barrier to critical and 
open-minded comments about daily practice. There were 
considerable differences in response rates across the countries 
(Table 1), which may be due to different recruitment meth-
ods. Participating GPs may be above-average be interested 
in this particular topic, and in general interested in reflective 
activities on clinical practice. The different moderators were 
trained in the research method and used the same interview 
guide; however, different moderation styles and different 
settings put emphasis on different topics in the discussions. 
Even though the research group members discussed the mean-
ing of phrases when in doubt, using translated transcripts for 
data analysis always carries the risk that phrases/ideas do not 
reflect their actual meaning. Finally, it has to be kept in mind 
that studying decision-making with FGDs can only tell us 
something about how decisions are thought to be made, not 
how they are made in the actual consultations.24
Conclusion
Fear of overlooking severe illness and of further deteriorat-
ing symptoms emerged as a main driver of GPs’ decision-
making regarding the management of patients with COPD 
exacerbations. Individual coping styles may partly explain 
variations in prescribing and high hospitalization rates. Yet, 
the perceived availability and reliability of other formal and 
informal carers to share responsibility with, and a functioning 
local infrastructure to ensure transportation to professional 
care is important for GPs to refrain from a “better safe 
than sorry” approach to decision-making. Other types of 
knowledge than biomedical knowledge, such as experiential 
knowledge of patients and GPs’ personal knowledge about a 
patient, should be acknowledged as valid conceptual resource 
for decision-making. Overall, our findings suggest that mul-
tiple stakeholders are involved in the management of COPD 
exacerbations, and that their approach to decision-making 
may not always be compatible with each other and with care 
goals of policy makers. This study suggests a collaborative 
approach to COPD management across all care sectors. 
Fruitful collaboration requires communication to address 
mismatches in perceived “appropriateness” of a decision, and 
clear areas of responsibilities between GPs, other health care 
professionals, patients, and their social network. This could 
be helpful to reduce hospitalization rates and unnecessary 
use of medications, and at the same time ensure monitoring 
of patients and prompt intervention if necessary.
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Supplementary material
Patient stories
1) A 60-year-old male patient with moderate COPD has 
called your practice and asked for medicine, due to 
increased coughing and shortness of breath the last week. 
He quit smoking a year ago. You have prescribed anti-
cholinergics for inhalation as maintenance medication. 
Now he thinks a course of antibiotics might be helpful. 
He was treated with amoxicillin and prednisolone last 
winter 9 months ago, and recovered after a few weeks.
2) A 70-year-old female patient, still smoking, visits 
your practice. She was hospitalized due to her COPD 
1 year ago. She uses a combination of inhaled corticos-
teroids and long acting beta2 agonists, and short acting 
beta2 agonists on demand. She had a common cold a 
week ago. Now she has no fever, but breathes heavily and 
rather fast. She had to sit in her bed last night, and she 
feels somewhat exhausted. Although you hear wheezes 
all over her chest, you do not think the obstruction is 
very severe. You believe her illness is worsened by her 
anxiety, but consider admitting her to hospital.
